Sepsis research honoured
Germany - The third Hugo Schottmüller Prize, awarded by the German Sepsis Society (DSG), has been presented to Dr Marc W Merx, of the Rheinisch-Westfälische Technical University (RWTH) Hospital, Aachen, for his paper 'HMG-CoA Reductase Inhibitor Simvastatin Profoundly Improves Survival in a Murine Model of Sepsis', published in the journal Circulation.
The DSG reported that Dr Merx and colleagues had described a promising starting point for a new sepsis therapy. They reported that the drug Simvastatin, which lowers blood cholesterol levels, increased the survival rate of mice suffering sepsis. Dr Merx’ work is a starting point for further investigations on a Simvastatin-based therapy for inflammation-related diseases.
Worth 3,000 euros, the DSG’s research prize is funded by SIRS-Lab GmbH.
01.03.2005
More on the subject:
